Grant: Master's Award: Canada Graduate Research Scholarships - Master's program
University of Alberta
$27,000.00
Mechanism of the stimulation of the type 1 interferon response mediated by depletion of polynucleotide phosphatase/kinase
EF 2025-26
Résumé
Polynucleotide kinase/phosphatase (PNKP) is a DNA repair enzyme, restoring the 5?-phosphate and 3?-hydroxyl termini required for repairing DNA strand breaks. Loss of PNKP leads to the accumulation of unrepaired DNA lesions and stimulates the innate immune response through the type I interferon (T1IFN) pathway.
Previous findings from Dr. Weinfeld’s lab indicated that: i) loss of PNKP leads to the release of damaged mitochondrial DNA (mtDNA) into the cytosol, which contributes to T1IFN activation; and ii) PNKP-mediated T1IFN response depends on the sensor protein ZBP1. This project further investigates the mechanisms of PNKP-mediated T1IFN response.
We hypothesize that loss of PNKP leads to the accumulation of damaged mtDNA, which is degraded by lysosomal DNase II. The resulting DNA fragments contain 3?-phosphate ends that cannot be processed without PNKP and are released into the cytosol. The accumulation of cytosolic mtDNA increases the opportunity for ZBP1 to bind and stimulate the T1IFN response.
Preliminary data suggested that DNase II plays a key role in PNKP-mediated T1IFN activation. To explore the route by which mtDNA encounters DNase II, GFP-tagged DNase II will be expressed, and its localization will be analyzed by fluorescence microscopy. Electron microscopy will be used to observe mitochondria-lysosome contacts and autophagosome formation. To test if ZBP1 binds to cytosolic mtDNA, HA-tagged ZBP1 will be transfected, followed by co-immunoprecipitation and qPCR to identify bound DNA. Western blotting will assess whether ZBP1 depletion impacts STING dimerization and STAT1 phosphorylation, key markers of T1IFN activation.
Overall, this project evaluates the potential of PNKP as a target to enhance cancer therapy by stimulating the anti-tumor immune response.
Programme
Master's Award: Canada Graduate Research Scholarships - Master's program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
572944
Name
Yu Haoxin (Amelia)
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mechanism of the stimulation of the type 1 interferon response mediated by depletion of polynucleotide phosphatase/kinase
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Anti-Tumor Immune Response; Cancer Therapy; Dna Repair / Dna End Processing; Dna Repair Inhibitors; Dna Strand Breaks; Lysosomal Dnase Ii; Mitochondrial Dna (Mtdna) Damage; Polynucleotide Phosphatase/Kinase (Pnkp); Type 1 Interferon (T1ifn) Response; Zbp1-Sting Pathway
Abstract
Polynucleotide kinase/phosphatase (PNKP) is a DNA repair enzyme, restoring the 5?-phosphate and 3?-hydroxyl termini required for repairing DNA strand breaks. Loss of PNKP leads to the accumulation of unrepaired DNA lesions and stimulates the innate immune response through the type I interferon (T1IFN) pathway.
Previous findings from Dr. Weinfeld’s lab indicated that: i) loss of PNKP leads to the release of damaged mitochondrial DNA (mtDNA) into the cytosol, which contributes to T1IFN activation; and ii) PNKP-mediated T1IFN response depends on the sensor protein ZBP1. This project further investigates the mechanisms of PNKP-mediated T1IFN response.
We hypothesize that loss of PNKP leads to the accumulation of damaged mtDNA, which is degraded by lysosomal DNase II. The resulting DNA fragments contain 3?-phosphate ends that cannot be processed without PNKP and are released into the cytosol. The accumulation of cytosolic mtDNA increases the opportunity for ZBP1 to bind and stimulate the T1IFN response.
Preliminary data suggested that DNase II plays a key role in PNKP-mediated T1IFN activation. To explore the route by which mtDNA encounters DNase II, GFP-tagged DNase II will be expressed, and its localization will be analyzed by fluorescence microscopy. Electron microscopy will be used to observe mitochondria-lysosome contacts and autophagosome formation. To test if ZBP1 binds to cytosolic mtDNA, HA-tagged ZBP1 will be transfected, followed by co-immunoprecipitation and qPCR to identify bound DNA. Western blotting will assess whether ZBP1 depletion impacts STING dimerization and STAT1 phosphorylation, key markers of T1IFN activation.
Overall, this project evaluates the potential of PNKP as a target to enhance cancer therapy by stimulating the anti-tumor immune response.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yu, Haoxin (Amelia)
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~